Daniel MBA - Phoenix Biotech Chief Officer

PBAXDelisted Stock  USD 10.90  0.00  0.00%   

Executive

Daniel MBA is Chief Officer of Phoenix Biotech Acquisition
Age 67
Phone215 731 9450
Webhttps://www.phoenixbiotechacquisitioncorp.com

Phoenix Biotech Management Efficiency

The company has return on total asset (ROA) of (0.0255) % which means that it has lost $0.0255 on every $100 spent on assets. This is way below average. Phoenix Biotech's management efficiency ratios could be used to measure how well Phoenix Biotech manages its routine affairs as well as how well it operates its assets and liabilities.
Phoenix Biotech Acquisition currently holds 650 K in liabilities. Phoenix Biotech Acqu has a current ratio of 13.6, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Phoenix Biotech's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 1 records

EXECUTIVE Age

Michael MinnickTarget Global Acquisition
57
Phoenix Biotech Acquisition Corp. does not have significant operations. The company was incorporated in 2021 and is based in Oakland, California. Phoenix Biotech is traded on NASDAQ Exchange in the United States. Phoenix Biotech Acquisition (PBAX) is traded on NASDAQ Exchange in USA and employs 4 people.

Management Performance

Phoenix Biotech Acqu Leadership Team

Elected by the shareholders, the Phoenix Biotech's board of directors comprises two types of representatives: Phoenix Biotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Phoenix. The board's role is to monitor Phoenix Biotech's management team and ensure that shareholders' interests are well served. Phoenix Biotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Phoenix Biotech's outside directors are responsible for providing unbiased perspectives on the board's policies.
MD MBA, President
Daniel MBA, Chief Officer
Christopher MBA, CEO Director
MBA MBA, Chief Officer

Phoenix Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Phoenix Biotech a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Consideration for investing in Phoenix Stock

If you are still planning to invest in Phoenix Biotech Acqu check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Phoenix Biotech's history and understand the potential risks before investing.
Global Correlations
Find global opportunities by holding instruments from different markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account